Nina Capital

A specialized venture capital firm investing exclusively at the intersection of healthcare and technology.

Venture Capital Active Barcelona, Spain Est. 2019
Visit website ↗ LinkedIn
Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
Pre-Seed, Seed, A Round

About

Nina Capital is a specialized venture capital firm that invests exclusively in healthcare technology, focusing on pre-seed and seed investments with the capacity for follow-on at Series A. The firm was founded in 2019 and is based in Barcelona, Spain. They back need-driven founders across global markets including Pan-European, the United States, Israel, Canada, and Australia. Nina Capital focuses on solutions that improve outcomes and address critical needs in health, leveraging information technology, data, and computing to transform healthcare. The firm explicitly avoids investments in drugs and vaccines.

Portfolio

No portfolio companies in this dataset yet.

Investment activity

Portfolio by sector

Health Tech & Life Sciences3

Funds · 2

  • 2 — $43M Feb 2022
  • 1 — $19.5M Jun 2021

Q&A

What is Nina Capital's primary investment focus?
Nina Capital primarily invests in Health Tech & Life Sciences companies, with all three of its listed portfolio companies operating in this sector.
What is Nina Capital's geographic investment scope?
Nina Capital invests broadly across Europe, including the United Kingdom, in the United States, Canada, Israel, and Australia.
Which funding stages does Nina Capital typically target?
Nina Capital focuses on Pre-Seed, Seed, and A Round investment stages.
When did Nina Capital close its second fund?
Nina Capital closed its second fund, Fund 2, in February 2022, raising $43M.
What was the size of Nina Capital's first fund?
Nina Capital's first fund, Fund 1, closed in June 2021 with $19.5M.
Can you name a notable portfolio company of Nina Capital?
Nina Capital's portfolio includes QuantHealth, an AI-Based Clinical Trial Simulation company that raised a $21.01M Series A round.
Who is a key founder at Nina Capital?
Marta G. Zanchi is a Founder & Managing Partner at Nina Capital.
What is Nina Capital's investment methodology?
Nina Capital's investment criteria and process are informed by the Stanford-born Biodesign methodology of health technology innovation, which applies a need-driven and value-based approach.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)